Global In Vitro Diagnostics Market to Reach USD 132.71 Billion by 2030, Driven by Rising Chronic Disease Prevalence and Demand for Personalized Testing
Mordor Intelligence has published a new report on the In Vitro Diagnostics (IVD) Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Global In Vitro Diagnostics (IVD) Market is projected to grow from USD 100.96 billion in 2025 to USD 132.71 billion by 2030, registering a compound annual growth rate (CAGR) of 5.62% during the forecast period. This growth is attributed to the increasing prevalence of chronic and infectious diseases, the rising demand for point-of-care diagnostics, and the growing acceptance of personalized medicine and companion diagnostics.
In Vitro Diagnostics Market Key Trends
-
Growing Burden of Chronic and Infectious Diseases
The rising incidence of chronic conditions such as coronary heart disease and infectious diseases like HIV is fueling the demand for IVD solutions. For instance, in December 2023, the Australian Institute of Health and Welfare reported that coronary heart disease is prevalent in approximately 11% of adults aged 75 years and above in Australia. Additionally, in July 2023, the United Nations Office for the Coordination of Humanitarian Affairs reported that around 39 million individuals were infected with HIV in 2022 worldwide. These statistics underscore the need for early and accurate diagnostic tools, thereby contributing to market growth.
-
Advancements in Diagnostic Technologies
There has been a shift from traditional diagnostics to advanced technologies that operate at the genetic level. Techniques such as genetic testing, molecular diagnostics, polymerase chain reaction (PCR), and next-generation sequencing (NGS) are increasingly integrated into IVD platforms. For example, in June 2023, Deyser launched a new diagnostic platform incorporating these advanced technologies, enhancing the accuracy and efficiency of diagnostic procedures.
-
Rise in Point-of-Care Testing
The demand for point-of-care (POC) diagnostics is on the rise due to the need for rapid and accurate testing, especially in remote and resource-limited settings. POC testing enables immediate clinical decisions, improving patient outcomes and reducing the burden on centralized laboratories. The increasing adoption of POC diagnostics is expected to significantly contribute to the growth of the IVD market.
In Vitro Diagnostics Market Segmentation
By Test Type:
- Clinical Chemistry
- Molecular Diagnostics
- Immunodiagnostics
- Hematology
- Other Test Types
By Product:
- Instruments
- Reagents
- Other Products
By Usability:
- Disposable IVD Devices
- Reusable IVD Devices
By Application:
- Infectious Disease
- Diabetes
- Cancer/Oncology
- Cardiology
- Autoimmune Disease
- Nephrology
- Other Applications
By End User:
- Diagnostic Laboratories
- Hospitals and Clinics
- Other End Users
By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
North America currently holds the largest market share, while the Asia-Pacific region is anticipated to experience the fastest growth during the forecast period.
Explore Our Full Library of Medical Devices Research Industry Reports –
https://www.mordorintelligence.com/market-analysis/medical-devices?utm_source=linkewire
In Vitro Diagnostics Market Key Players
The IVD market is characterized by high market concentration, with several major companies leading the industry:
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Abbott
- Siemens Healthineers AG
- bioMérieux
These companies are actively engaged in expanding their product portfolios and enhancing their global presence to meet the growing demand for advanced diagnostic solutions.
Find out our latest Blog Article on Biopharmaceutical In Vitro Diagnostics Market:
Conclusion
The global In Vitro Diagnostics market is poised for significant growth, driven by the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and the rising demand for point-of-care testing. With North America leading in market share and the Asia-Pacific region emerging as the fastest-growing market, stakeholders in the IVD industry are presented with substantial opportunities for expansion and innovation. As the healthcare landscape continues to evolve, the role of IVD in disease detection and management will become increasingly vital.
Industry Related Reports
South Africa In-Vitro Diagnostics (IVD) Market : The South Africa In-Vitro Diagnostics is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Test Types), Product (Instruments, Reagents, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users).
UK In-Vitro Diagnostics (IVD) Market: The UK Molecular Diagnostics Market Report is Segmented by Technique (Clinical Chemistry, Molecular Diagnostics Immuno Diagnostics and Other Techniques), Product (Instrument, Reagent and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology and Other Applications) and End User (Diagnostics Laboratories, Hospitals and Clinics and Other End Users).
United States In Vitro Diagnostics Market: The United States In Vitro Diagnostics Market is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Haematology, and Other Test Types), Product (Instruments, Reagents, and Other Products), Usability (Disposable IVD and Reusable IVD), Application (Infectious Diseases, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users).
China In-vitro Diagnostics (IVD) Market : The China In-Vitro Diagnostics Market is Segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Other Types), Product (Instrument, Reagent, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/